Skip to content

Pain comparison in keloid treatment with intralesional corticosteroid injection with local anesthetic and without local anesthetic

Pain comparison in keloid treatment with intralesional corticosteroid injection with local anesthetic and without local anesthetic

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20230713005
Enrollment
28
Registered
2023-07-13
Start date
2023-07-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keloid Keloid Intralesional injection Local anesthetic

Interventions

Intralesional corticosteroid injection mixture of corticosteroid and lidocaine,Intralesional corticosteroid injection mixture of corticosteroid and normal saline
Active Comparator Drug,Experimental Drug
Corticosteroid with local anesthetic,Corticosteroid without local anesthetic

Sponsors

Institute of Dermatology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Male and female patients. 2. Aged 18 years and above. 3. New patients receiving treatment at the Dermatology Institute, clinically diagnosed with keloid scars. Patients must have keloid scars no larger than 5 centimeters, amounting to two spots in the same area of the body. They should have received localized steroid injections at a concentration of 20 mg/ml in the scar area. 4. Must be able to read and communicate clearly in Thai.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of allergies to the treatment substances, namely steroids and sedatives. 2. Patients with conditions that contraindicate localized steroid injections, such as infections or inflammations at the site of injection. 3. Patients for whom localized steroid injections are contraindicated, such as patients taking anticoagulants, increasing the risk of bleeding disorders.

Design outcomes

Primary

MeasureTime frame
Pain outcome After injection Visual analog scale

Secondary

MeasureTime frame
N/A N/A N/A

Countries

Thailand

Contacts

Public ContactSarun Jantrakulroj

Institute of dermatology

searth22@gmail.com0869965665

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026